Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Skin Diseases, Bacterial
Diseases [C] » Infections [C01] » Skin Diseases, Infectious » Skin Diseases, Bacterial
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Infectious » Skin Diseases, Bacterial
Description
Skin diseases caused by bacteria. MeSH
Hierarchy View
Subtype Terms (16)
Digital Dermatitis
7 drugs (5 approved, 2 experimental)
Ecthyma
2 approved drugs
Erysipelas
4 drugs (3 approved, 1 experimental)
Erythema Chronicum Migrans
4 approved drugs
Erythrasma
1 approved drug
Granuloma Inguinale
2 approved drugs
Hidradenitis Suppurativa
68 drugs (37 approved, 31 experimental)
Mycetoma
2 experimental drugs
Rhinoscleroma
4 approved drugs
Staphylococcal Skin Infections
38 drugs (30 approved, 8 experimental)
Yaws
7 approved drugs
Approved Indicated Drugs (18)
Phase 4 Indicated Drugs (4)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
